Literature DB >> 3129726

Variable region framework differences result in decreased or increased affinity of variant anti-digoxin antibodies.

D J Panka1, M Mudgett-Hunter, D R Parks, L L Peterson, L A Herzenberg, E Haber, M N Margolies.   

Abstract

Rare spontaneous variants of the anti-digoxin antibody-producing hybridoma 40-150 (Ko = 5.4 x 10(9) M-1) were selected for altered antigen binding by two-color fluorescence-activated cell sorting. The parent antibody binds digoxin 890-fold greater than digitoxin. The variant 40-150 A2.4 has reduced affinity for digoxin (Ko = 9.2 x 10(6) M-1) and binds digoxin 33-fold greater than digitoxin. A second-order variant, derived from 40-150 A2.4 (designated 40-150 A2.4 P.10), demonstrated partial regain of digoxin binding (Ko = 4.4 x 10(8) M-1). The altered binding of the variant 40-150 A2.4 was accounted for by a point mutation resulting in substitution of arginine for serine at position 94 in the heavy chain variable region. Antibody 40-150 A2.4 P.10 also contains this arginine but owes its enhanced antigen binding to deletion of two amino acids from the heavy chain amino terminus. This unusual sequence alteration in an immunoglobulin framework region confers increased affinity for antigen.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3129726      PMCID: PMC280147          DOI: 10.1073/pnas.85.9.3080

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Characterization of antibodies of high affinity and specificity for the digitalis glycoside digoxin.

Authors:  T W Smith; V P Butler; E Haber
Journal:  Biochemistry       Date:  1970-01-20       Impact factor: 3.162

2.  Variability of three-dimensional structure in immunoglobulins.

Authors:  E A Padlan; D R Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

3.  High-affinity monoclonal antibodies to the cardiac glycoside, digoxin.

Authors:  M M Hunter; M N Margolies; A Ju; E Haber
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

Review 4.  Somatic generation of antibody diversity.

Authors:  S Tonegawa
Journal:  Nature       Date:  1983-04-14       Impact factor: 49.962

5.  Single amino acid substitution altering antigen-binding specificity.

Authors:  S Rudikoff; A M Giusti; W D Cook; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

6.  Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0 A and 1.0 A resolution.

Authors:  M Marquart; J Deisenhofer; R Huber; W Palm
Journal:  J Mol Biol       Date:  1980-08-25       Impact factor: 5.469

7.  Preliminary refinement and structural analysis of the Fab fragment from human immunoglobulin new at 2.0 A resolution.

Authors:  F A Saul; L M Amzel; R J Poljak
Journal:  J Biol Chem       Date:  1978-01-25       Impact factor: 5.157

8.  Subcellular localization and levels of aminopeptidases and dipeptidase in Saccharomyces cerevisiae.

Authors:  J Frey; K H Röhm
Journal:  Biochim Biophys Acta       Date:  1978-11-10

9.  Somatic mutation in a cultured mouse myeloma cell affects antigen binding.

Authors:  W D Cook; S Rudikoff; A M Giusti; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  13 in total

1.  Paracrine inhibition of prion propagation by anti-PrP single-chain Fv miniantibodies.

Authors:  Gaetano Donofrio; Frank L Heppner; Magdalini Polymenidou; Christine Musahl; Adriano Aguzzi
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  Filamentous bacteriophage display of a bifunctional protein A::scFv fusion.

Authors:  Y Li; W Cockburn; G C Whitelam
Journal:  Mol Biotechnol       Date:  1998-06       Impact factor: 2.695

3.  Protein evolution on rugged landscapes.

Authors:  C A Macken; A S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

4.  Modulation of antibody affinity by a non-contact residue.

Authors:  J F Schillbach; R I Near; R E Bruccoleri; E Haber; P D Jeffrey; J Novotny; S Sheriff; M N Margolies
Journal:  Protein Sci       Date:  1993-02       Impact factor: 6.725

5.  Contribution of a single heavy chain residue to specificity of an anti-digoxin monoclonal antibody.

Authors:  J F Schildbach; S Y Shaw; R E Bruccoleri; E Haber; L A Herzenberg; G C Jager; P D Jeffrey; D J Panka; D R Parks; R I Near
Journal:  Protein Sci       Date:  1994-05       Impact factor: 6.725

6.  Immunoglobulin heavy chain gene expression in peripheral blood B lymphocytes.

Authors:  C Huang; A K Stewart; R S Schwartz; B D Stollar
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

7.  Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.

Authors:  J S Huston; D Levinson; M Mudgett-Hunter; M S Tai; J Novotný; M N Margolies; R J Ridge; R E Bruccoleri; E Haber; R Crea
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

8.  Human monoclonal antibodies with different fine specificity for digoxin derivatives: cloning of heavy and light chain variable region sequences.

Authors:  L Danielsson; C Furebring; M Ohlin; L Hultman; M Abrahamson; R Carlsson; C A Borrebaeck
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

9.  Anti-digoxin Fab variants generated by phage display.

Authors:  Viviane Midori Murata; Mariana Costa Braga Schmidt; Jorge Kalil; Lilian Rumi Tsuruta; Ana Maria Moro
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

10.  Mutational analysis of an autoantibody: differential binding and pathogenicity.

Authors:  J B Katz; W Limpanasithikul; B Diamond
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.